The Meaning of Lymphadenopathies During Adjuvant Durvalumab After Chemoradiotherapy for Lung Cancer: Thinking Beyond Disease Progression - Correction
AuthID
P-019-5SA
P-019-5SA
© 2025 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service